Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Frontiers in Molecular Biosciences

Topics

Biology

Bioinformatics

Computer Science

Chemistry

Medicine

Show all topics

DOI

10.3389/fmolb.2024.1413214

License

CC-BY

Other Formats

PDF